From: Antimullerian hormone is a predictor of live birth in patients with recurrent pregnancy loss
Outcomes by AMH level: (n = 155 patients) | Age (Mean ± SD) | Pregnancies per patient, N (%) | LBR per pregnancy, N (%) | CMR per pregnancy, N (%) | Time to Pregnancy, months (Mean ± SD) |
---|---|---|---|---|---|
AMH < 0.5 (n = 28) | 37.9 ± 4.0 | 14 (50%) | 5 (36%) | 9 (64%) | 4.8 ± 3.7 |
AMH 0.5–0.99 (n = 19) | 36.4 ± 3.1 | 14 (74%) | 6 (43%) | 8 (57%) | 4.8 ± 2.7 |
AMH 1–1.99 (n = 41)* | 35.3 ± 6.2 | 30 (73%) | 17 (57%) | 12 (40%) | 3.9 ± 2.2 |
AMH 2–2.99 (n = 24) | 35.0 ± 3.9 | 16 (67%) | 12 (75%) | 4 (25%) | 4.6 ± 2.3 |
AMH ≥ 3 (n = 43) | 33.7 ± 3.4 | 29 (67%) | 21 (72%) | 8 (28%) | 4.6 ± 3.3 |